Ammonia Monitoring in Hepatic Encephalopathy Management

Guideline Recommendations

The American Association for the Study of Liver Diseases (AASLD) guidance explicitly states that routine ammonia level testing in patients with cirrhosis and altered mental status is not recommended 1
A low ammonia level can help rule out hepatic encephalopathy (HE) as the cause of altered mental status 1

For patients with significant initial elevation of ammonia, treatment verification is necessary, and rechecking ammonia levels can help determine whether to continue, adjust, or discontinue therapy 4
If the patient is asymptomatic with normal mental status, continuing lactulose at the current dose can be considered 2, 5
Lactulose continuation depends on the underlying cause, and for hepatic encephalopathy prevention after episodes, long-term lactulose can be continued to maintain 2-3 soft bowel movements daily 2, 5, 4

Monitor clinical status (mental status, asterixis, confusion) rather than ammonia levels 1
Ensure patient maintains 2-3 soft bowel movements daily as the therapeutic endpoint 2, 5, 4
Consider adding rifaximin 550 mg twice daily if patient has recurrent episodes (defined as ≥2 episodes in 6 months), as this reduces recurrence risk from 46% to 22% 2, 5

Do not chase ammonia levels, as clinical improvement matters more than absolute ammonia values 1
Do not over-titrate lactulose, as excessive diarrhea causes dehydration and electrolyte abnormalities that can worsen encephalopathy 4
Do not discontinue lactulose abruptly in cirrhotic patients, as those with prior HE episodes need long-term secondary prophylaxis 2, 5